Potential risk of tamoxifen: gut microbiota and inflammation in mice with breast cancer.

Li, Hailong; Gao, Xiufei; Chen, Yian; Wang, Mengqian; Xu, Chuchu; Yu, Qinghong; Jin, Ying; Song, Jiaqing; Zhu, Qi

Li, Hailong; Gao, Xiufei; Chen, Yian; Wang, Mengqian; Xu, Chuchu; Yu, Qinghong; Jin, Ying; Song, Jiaqing; Zhu, Qi.

Afiliação

Li H; School of Green Intelligent Pharmaceutical Industry, Zhejiang Guangsha Vocational and Technical University of Construction, Dongyang, Zhejiang, China.
Gao X; Department of Breast Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
Chen Y; First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Wang M; First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Xu C; First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Yu Q; First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Jin Y; First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Song J; First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Zhu Q; Department of Breast Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.

Front Oncol ; 13: 1121471, 2023.

Article em En | MEDLINE | ID: mdl-37469407

Palavras-chave

TLR5; breast cancer; gut microbiota; inflammation; tamoxifen

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google